
Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
Keywords: Panobinostat; Histone deacetylase inhibitors; LBH589; Non-small cell lung cancer; Epigenetic therapy;